Marty Makary serves as FDA Commissioner overseeing drug approvals and advocates for psychedelic therapies in clinical settings.
1 report, 1 independent
Updated Jul 13
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Marty Makary serves as FDA Commissioner overseeing drug approvals and advocates for psychedelic therapies in clinical settings.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
- FDA
-
Marty Makary
American surgeon and FDA Commissioner
Nothing else this week.
-
Robert F. Kennedy Jr.
American politician, environmental lawyer, anti-vaccine activist, and conspiracy theorist (born 1954)
- Robert F. Kennedy Jr. visited Clinton Township to announce funding as part of Donald Trump's Great American Recovery Initiative.
- An outbreak in Lancaster County, Pennsylvania, has drawn comments from officials regarding vaccine policy, involving figures like Robert F. Kennedy Jr. and those connected to Donald Trump.
Related events
- An Executive Order has been issued mandating accelerated research into psychedelic therapies through partnerships between various bodies.
- Faculty from Dartmouth College and the National Academy of Medicine testified regarding psilocybin research for the FDA.
- Richard Langford provided expert comments on psychedelic drug access and is receiving feedback on clinical psychedelic programs.
- Former FDA administrator Marty Makary is involved in events where FDA actions are questioned, monitored by Nassau County legislature, and Judy Jacobs is present.
- The administration has signed an executive order and issued priority vouchers to accelerate the drug approval process through the FDA.